Hypolipidemic effect and mechanism of Hedan tablet(荷丹片)based on network pharmacology
Hypolipidemic effect and mechanism of Hedan tablet(荷丹片)based on network pharmacology
摘要
关键词
hyperlipidemia/mechanism/network pharmacology/ultra-performance liquid chromatography-quadrupole-time-of-flight-tandem mass spectrometry/Hedan tabletKey words
hyperlipidemia/mechanism/network pharmacology/ultra-performance liquid chromatography-quadrupole-time-of-flight-tandem mass spectrometry/Hedan tablet引用本文复制引用
HU Huiming,WENG Jiajun,TANG Fangrui,WANG Yaqi,FAN Shengxian,WANG Xuecheng,CUI Can,SHAO Feng,ZHU Yanchen..Hypolipidemic effect and mechanism of Hedan tablet(荷丹片)based on network pharmacology[J].中医杂志(英文版),2025,45(2):408-421,14.基金项目
Supported by the National Natural Science Foundation of China:Effects of Hawthorn Leaves Flavonoids on Atherosclerosis Unstable Plaques based on the Mechanism of Liver-gut axis Liver X Receptor(LXR-a)-mediated Iron and Lipid Metabolism Disorders(No.82260794),the Natural Science Foundation of Jiangxi Province:based on Secreted Phospholipase A2 Type ⅡA(sPLA2-ⅡA)Regulating Lipid Mediated Foam Cell Formation to Explore the Effect and Molecular Mechanism of Hawthorn Leaf Flavonoids on Anti-atherosclerosis(No.20212BAB206013),the Key R&D Program of Jiangxi Province:Research on the Quality Enhancement and Industrialization Technology Improvement of the Lipid-Lowering Traditional Chinese Medicine"Hedan Tablet"(No.20201BBG71005),Science and Technology Project of Jiangxi Provincial Department of Education:based on the"Phlegm-Stasis"Theory to Explore the Effects and Molecular Mechanisms of Hawthorn Leaves Flavonoids on Improving Iron and Lipid Metabolism Disorders in Atherosclerosis(No.GJJ2203502) (LXR-a)